News & Articles
Cystic Fibrosis patients with the defect G551D mutation may benefit from the FDA’s approval of Kalydeco. Kalydeco is the first drug that targets the underlying causes of Cystic Fibrosis. Children’s Mercy Hospital in Kansas City, a partner of WRI, helped trial the drug. For the past seven years, WRI has given $600,000 with 100% of […]Continue reading
STOP SMOKING — FREE APP AVAILABLE Longtime partners in pulmonary rehabilitation and smoking cessation, the Will Rogers Institute and Patricia Neal Rehabilitation Center, a member of Covenant Health in Knoxville, Tennessee, joined together to create a smartphone app with tried-and-true strategies that will help people quit smoking. “As part of our not-for-profit mission, we are […]Continue reading
Ingredients: 5 cups acorn squash, peeled and cut into 3/4″ pieces 1 cup wild rice, uncooked 3 cups reduced sodium vegetable broth 1 tbsp. extra virgin olive oil 1 medium onion, finely chopped ¾ cup celery, finely chopped ½ cup almonds, chopped and toasted ½ cup dried apricots, chopped ½ cup dried cranberries 1 tbsp. […]Continue reading
Ingredients: 1 ea. pear, peeled and finely chopped 3 tbsp. apple juice 3 tbsp. lemon juice 1 tbsp. fat free sour cream 1 head butter lettuce 2 ea. pear, peeled, cored and thinly sliced 1 lb. turkey breast, roasted 2 cup watercress sprigs, lightly packed, rinsed and crisped 1 oz. blue cheese, crumbled 2 tsp. […]Continue reading
To perpetuate the memory of Will Rogers by promoting and funding medical research of cardiopulmonary diseases, purchasing neonatal ventilator equipment for medical facilities across the country and by educating the general public on topics of health and fitness.